BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 21193314)

  • 1. Structural and biochemical study on the inhibitory activity of derivatives of 5-nitro-furan-2-carboxylic acid for RNase H function of HIV-1 reverse transcriptase.
    Yanagita H; Urano E; Matsumoto K; Ichikawa R; Takaesu Y; Ogata M; Murakami T; Wu H; Chiba J; Komano J; Hoshino T
    Bioorg Med Chem; 2011 Jan; 19(2):816-25. PubMed ID: 21193314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivatives of 5-nitro-furan-2-carboxylic acid carbamoylmethyl ester inhibit RNase H activity associated with HIV-1 reverse transcriptase.
    Fuji H; Urano E; Futahashi Y; Hamatake M; Tatsumi J; Hoshino T; Morikawa Y; Yamamoto N; Komano J
    J Med Chem; 2009 Mar; 52(5):1380-7. PubMed ID: 19178289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational and Crystallographic Analysis of Binding Structures of Inhibitory Compounds for HIV-1 RNase H Activity.
    Lu H; Komukai Y; Usami K; Guo Y; Qiao X; Nukaga M; Hoshino T
    J Chem Inf Model; 2022 Dec; 62(24):6762-6774. PubMed ID: 36184946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural modulation study of inhibitory compounds for ribonuclease H activity of human immunodeficiency virus type 1 reverse transcriptase.
    Yanagita H; Fudo S; Urano E; Ichikawa R; Ogata M; Yokota M; Murakami T; Wu H; Chiba J; Komano J; Hoshino T
    Chem Pharm Bull (Tokyo); 2012; 60(6):764-71. PubMed ID: 22689429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone.
    Borkow G; Fletcher RS; Barnard J; Arion D; Motakis D; Dmitrienko GI; Parniak MA
    Biochemistry; 1997 Mar; 36(11):3179-85. PubMed ID: 9115994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNase H active site inhibitors of human immunodeficiency virus type 1 reverse transcriptase: design, biochemical activity, and structural information.
    Kirschberg TA; Balakrishnan M; Squires NH; Barnes T; Brendza KM; Chen X; Eisenberg EJ; Jin W; Kutty N; Leavitt S; Liclican A; Liu Q; Liu X; Mak J; Perry JK; Wang M; Watkins WJ; Lansdon EB
    J Med Chem; 2009 Oct; 52(19):5781-4. PubMed ID: 19791799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones.
    Budihas SR; Gorshkova I; Gaidamakov S; Wamiru A; Bona MK; Parniak MA; Crouch RJ; McMahon JB; Beutler JA; Le Grice SF
    Nucleic Acids Res; 2005; 33(4):1249-56. PubMed ID: 15741178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug targeting of HIV-1 RNA.DNA hybrid structures: thermodynamics of recognition and impact on reverse transcriptase-mediated ribonuclease H activity and viral replication.
    Li TK; Barbieri CM; Lin HC; Rabson AB; Yang G; Fan Y; Gaffney BL; Jones RA; Pilch DS
    Biochemistry; 2004 Aug; 43(30):9732-42. PubMed ID: 15274628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of HIV-1 reverse transcriptase (HIV-1 RT) RNase H by small RNA hairpins and dumbbells.
    Hannoush RN; Carriero S; Min KL; Damha MJ
    Chembiochem; 2004 Apr; 5(4):527-33. PubMed ID: 15185377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase.
    Meleddu R; Cannas V; Distinto S; Sarais G; Del Vecchio C; Esposito F; Bianco G; Corona A; Cottiglia F; Alcaro S; Parolin C; Artese A; Scalise D; Fresta M; Arridu A; Ortuso F; Maccioni E; Tramontano E
    ChemMedChem; 2014 Aug; 9(8):1869-79. PubMed ID: 24850787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human immunodeficiency virus type 1 reverse transcriptase, RNase H, and integrase activities by hydroxytropolones.
    Didierjean J; Isel C; Querré F; Mouscadet JF; Aubertin AM; Valnot JY; Piettre SR; Marquet R
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4884-94. PubMed ID: 16304149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and RDDP functions.
    Corona A; Onnis V; Deplano A; Bianco G; Demurtas M; Distinto S; Cheng YC; Alcaro S; Esposito F; Tramontano E
    Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28859311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structures for HIV-1 reverse transcriptase in complexes with three pyridinone derivatives: a new class of non-nucleoside inhibitors effective against a broad range of drug-resistant strains.
    Himmel DM; Das K; Clark AD; Hughes SH; Benjahad A; Oumouch S; Guillemont J; Coupa S; Poncelet A; Csoka I; Meyer C; Andries K; Nguyen CH; Grierson DS; Arnold E
    J Med Chem; 2005 Dec; 48(24):7582-91. PubMed ID: 16302798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New anthraquinone derivatives as inhibitors of the HIV-1 reverse transcriptase-associated ribonuclease H function.
    Esposito F; Corona A; Zinzula L; Kharlamova T; Tramontano E
    Chemotherapy; 2012; 58(4):299-307. PubMed ID: 23128501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrate-dependent inhibition or stimulation of HIV RNase H activity by non-nucleoside reverse transcriptase inhibitors (NNRTIs).
    Hang JQ; Li Y; Yang Y; Cammack N; Mirzadegan T; Klumpp K
    Biochem Biophys Res Commun; 2007 Jan; 352(2):341-50. PubMed ID: 17113568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of mutations in the polymerase domain on the polymerase, RNase H and strand transfer activities of human immunodeficiency virus type 1 reverse transcriptase.
    Gao HQ; Boyer PL; Arnold E; Hughes SH
    J Mol Biol; 1998 Apr; 277(3):559-72. PubMed ID: 9533880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a series of 3-hydroxyquinolin-2(1H)-ones as selective inhibitors of HIV-1 reverse transcriptase associated RNase H activity.
    Suchaud V; Bailly F; Lion C; Tramontano E; Esposito F; Corona A; Christ F; Debyser Z; Cotelle P
    Bioorg Med Chem Lett; 2012 Jun; 22(12):3988-92. PubMed ID: 22607675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing and Evaluating Inhibitors against the RNase H Active Site of HIV-1 Reverse Transcriptase.
    Boyer PL; Smith SJ; Zhao XZ; Das K; Gruber K; Arnold E; Burke TR; Hughes SH
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule inhibitors targeting HIV-1 reverse transcriptase dimerization.
    Grohmann D; Corradi V; Elbasyouny M; Baude A; Horenkamp F; Laufer SD; Manetti F; Botta M; Restle T
    Chembiochem; 2008 Apr; 9(6):916-22. PubMed ID: 18318036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is affected by the thumb subdomain of the small protein subunits.
    Sevilya Z; Loya S; Hughes SH; Hizi A
    J Mol Biol; 2001 Aug; 311(5):957-71. PubMed ID: 11531332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.